Partners in research
​
The activities of the Foundation for Liver and Gastrointestinal Research with respect to stimulation of clinical and scientific studies as well as educational meetings are financially supported by the following companies and organizations (in 2023-2024):
AbbVie B.V.
Advanz Pharma Services (UK) Limited
Alexion Pharmaceuticals
Aligos Therapeutic, Inc.
AMBU A/S
Astellas Pharma B.V.
AstraZeneca B.V.
Boston Scientific
Bristol-Myers Squibb International Corporation
Calliditas Therapeutic Suisse SA
Chiesi Pharmaceuticals B.V.
Cook Research Incorporated
CymaBay Therapeutics, Inc
Dr. Falk Pharma Benelux B.V.
Echosens
Eisai B.V.
ERBE Elektromedizin GmbH
Fujifilm Healthcare Europe GmbH
Fujirebio Europe N.V.
Galapagos NV
Gilead Sciences, Inc
GlaxoSmithkline BV
Intercept Pharmaceuticals Inc
International Grants Administration Inc (IGA)
Interscope Medical Inc.
Ipsen Innovation S.A.S.
IQVIA
Janssen-Cilag B.V.
Lilly Nederland B.V.
Lucid Diagnostics, Inc.
Micro-tech Nederland
Mirum Pharmaceuticals International B.V.
Novartis Pharme B.V.
Novo Nordisk B.V.
PAREXEL International IRL Ltd
Pentax Europe GmbH
Pfizer B.V.
Pharmaceutical Research Associates Group BV
Roche Diagnostics International Ltd
Roche Diagnostics Nederland BV
Schallware GmbH
Stichting Latoer
Stichting TransIT
Swedish Orphan Biovitrum
Syneos Health UK Limited
Takeda Nederland
Twin Pharma
Vir Biotechnology, Inc.
The Foundation would also like to express its gratitude to all private donors for their
generous support and contributions